P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
about
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology.Heme Oxygenases in Cardiovascular Health and Disease.Biological signaling by carbon monoxide and carbon monoxide-releasing molecules.Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension.CCR5 as a treatment target in pulmonary arterial hypertension.CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression.Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs.mTOR pathway activation drives lung cell senescence and emphysema.miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy.Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.Carbon monoxide-releasing molecule-3 protects against ischemic stroke by suppressing neuroinflammation and alleviating blood-brain barrier disruption.An Overview of the Potential Therapeutic Applications of CO-Releasing Molecules
P2860
Q28072348-D58D5FE4-ABC0-4A6B-B35E-5BD8D5A1078EQ38262595-B885AF71-B45B-4172-8B36-22E3BF17E466Q38823562-0BD903C0-D2EA-43ED-80B1-C473C9861F05Q39080342-8B89B9CD-CD43-4A31-A16D-1A5ADA55EF0CQ40855297-9ADE954B-FCA5-4207-88CC-3A5AA0DC4269Q42020850-AEF77889-EFA5-439A-B123-1B6599C70CD5Q42316580-0F90C593-C844-4426-988E-2B0FA9542400Q48101216-5FBC741A-C978-4B3D-B75E-22825724CBE9Q50130565-318890BB-9A7C-4FD0-A3D2-CD91C16A5658Q53095027-328CBF04-7A37-4B8B-984F-8FF80B049279Q55026570-762516EB-DA33-4C4D-A450-1984EB7ECFDCQ55452849-141F1530-889F-4211-B749-3E6E6A967A98Q57318137-CE74F046-2C5B-402E-9602-3184E3EF491C
P2860
P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
P21-dependent protective effec ...... e-3 in pulmonary hypertension.
@en
P21-dependent protective effec ...... e-3 in pulmonary hypertension.
@nl
type
label
P21-dependent protective effec ...... e-3 in pulmonary hypertension.
@en
P21-dependent protective effec ...... e-3 in pulmonary hypertension.
@nl
prefLabel
P21-dependent protective effec ...... e-3 in pulmonary hypertension.
@en
P21-dependent protective effec ...... e-3 in pulmonary hypertension.
@nl
P2093
P50
P1476
P21-dependent protective effec ...... e-3 in pulmonary hypertension.
@en
P2093
Amal Houssaïni
Elisabeth Marcos
Jean Luc Dubois-Randé
Nathalie Mouraret
Serge Adnot
Shariq Abid
Valerie Amsellem
P304
P356
10.1161/ATVBAHA.113.302302
P407
P577
2013-12-12T00:00:00Z